SEER
TechnologySeer Inc - Class A
Live · NASDAQ · May 9, Close
What's Moving SEER Today?
No stock-specific AI insight has been generated for SEER yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
SEER News
20 articles- How Seer (SEER) Is Rewriting Its Story With New Targets And Activist PressureYahoo Finance·May 6, 2026
- Seer Announces Appointment of Anthony Bazarko as Chief Commercial OfficerYahoo Finance·May 4, 2026
- Seer to Report First Quarter 2026 Financial Results on May 13, 2026Yahoo Finance·Apr 29, 2026
- The Radoff-JEC Group Responds to Seer, Inc.’s Rejection of April 24th Acquisition ProposalYahoo Finance·Apr 29, 2026
- Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC GroupYahoo Finance·Apr 27, 2026
- The Radoff-JEC Group Submits Improved Non-Binding Proposal to Acquire Seer, Inc.Yahoo Finance·Apr 24, 2026
- Uncovering Opportunities: Penny Stocks To Watch In April 2026Yahoo Finance·Apr 17, 2026
- Sector Update: Health Care Stocks Advance Late AfternoonYahoo Finance·Apr 13, 2026
- Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC GroupGlobeNewswire Inc.·Apr 13, 2026
- Sector Update: Health Care Stocks Softer Monday AfternoonYahoo Finance·Apr 13, 2026
- The Radoff-JEC Group Submits Non-Binding Proposal to Acquire Seer, Inc.Yahoo Finance·Apr 13, 2026
- Thermo Fisher Stock May Benefit Following Collaboration With PRECISEYahoo Finance·Apr 10, 2026
- Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K SamplesYahoo Finance·Apr 9, 2026
- PreOmics GmbH and Biognosys AG Prevail in U.S. Patent ChallengeYahoo Finance·Mar 31, 2026
- Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker SubsidiariesYahoo Finance·Mar 30, 2026
- Bullish Seer Insiders Loaded Up On US$5.29m Of StockYahoo Finance·Mar 29, 2026
- The Radoff-JEC Group Sends Open Letter to Seer, Inc. Unconflicted Independent Directors Meeta Gulyani and Nicolas RoelofsYahoo Finance·Mar 4, 2026
- Seer, Inc. Q4 2025 Earnings Call SummaryMoby·Feb 27, 2026
- Seer Q4 Earnings Call HighlightsMarketbeat·Feb 27, 2026
- Seer Inc (SEER) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Funding ChallengesYahoo Finance·Feb 27, 2026
All 20 articles loaded
Price Data
Fundamentals
Trading
About Seer Inc - Class A
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.